Back to top

RenaissanceRe's (RNR) Q4 Earnings Beat Estimates, Down Y/Y

Read MoreHide Full Article

RenaissanceRe Holdings Ltd. (RNR - Free Report) delivered fourth-quarter 2018 operating earnings per share of 2 cents, comparing favorably with the Zacks Consensus Estimate of operating loss of $1.93 per share. The result was backed by superior underwriting, higher revenues and application of gross-to-net strategy. However, the bottom line declined substantially by 98% year over year.

The quarter under review witnessed many catastrophic events.

Quarterly Operational Update

RenaissanceRe’s fourth-quarter operating revenues of $633 million surpassed the Zacks Consensus Estimate by 16%. The top line also improved 27.4% year over year, driven by higher net premiums earned.

RenaissanceRe Holdings Ltd. Price, Consensus and EPS Surprise

RenaissanceRe Holdings Ltd. Price, Consensus and EPS Surprise | RenaissanceRe Holdings Ltd. Quote

Gross premiums written surged 34.3% year over year to $547 million owing to higher premiums in the Property as well as the Casualty and Specialty segments.

Net investment income came in at $53 million, down 27.4% year over year due to losses on private equity and catastrophe bond investments. However, this downside was partially offset by higher returns on its fixed maturity and short-term investment portfolios.

RenaissanceRe’s total expenses were $680.8 million, up 52% year over year, primarily on higher net claims and claim expenses, acquisition expenses and operational expenses.

Underwriting loss of $82.3 million was wider than the year-ago quarter’s loss of $10.4 million.

Combined ratio was 114.3% for the fourth quarter compared with the year-ago quarter’s tally of 102.5%.

Quarterly Segment Update

Property Segment


Gross premiums written were $199.9 million up 110.1% % year over year, led by higher premiums written in catastrophe class of business.

Underwriting loss of $35 million due to Hurricane Michael, California Wildfires and changes in the 2018 Aggregate losses was wider than the year-ago quarter’s underwriting loss of $22.7 million. Combined ratio of 110.6% is flat with the year-ago quarter’s metric.

Casualty and Specialty Segment

Gross premiums written were $347.8 million, up 11.3% from the prior-year quarter. This upside is driven by continued and selective growth from new business opportunities within a few classes of business.

The company incurred underwriting loss of $47.4 million against the year-ago quarter’s income of $11.5 million.

Combined ratio of 119.3% expanded 2480 basis points year over year.

Financial Position  

As of Dec 31, 2018, total assets of RenaissanceRe were $18.7 billion, up 23% from 2017-end level.

The company had total debt of $991 million as of Dec 31 2018, up 0.1% from the level at 2017 end.

Cash and cash equivalents were $1107 million, down 18.7% from the tally at 2017 end.

Book value per share of $104.1 rose 4.4% year over year.

Return on equity for the quarter under review is 0.1%.

Full-Year Highlights

Revenues for the year dipped 1.4% to $2.1 billion. The company delivered net income of $4.91 per share versus the prior year's net loss of $6.15.

Zacks Rank

RenaissanceRe carries a Zacks Rank #3 (Hold).

Performance of Other Insurers

Of the insurance industry players that have reported fourth-quarter earnings so far, The Travelers Companies, Inc. (TRV - Free Report) and RLI Corp.’s (RLI - Free Report) earnings beat the respective Zacks Consensus Estimate while the metric of The Progressive Corporation (PGR - Free Report) missed the same. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?

From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.

This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.

See Stocks Today >>



More from Zacks Analyst Blog

You May Like